Literature DB >> 9090657

Urinary tract infections in girls: the cost-effectiveness of currently recommended investigative routines.

H Stark1.   

Abstract

Current recommendations for the universal investigation of urinary tract infection (UTI) in children by ultrasonography, voiding cystourethrography, and dimercaptosuccinic acid renal scan (and sometimes intravenous pyelography as well) are not based on any convincing evidence as to the necessity or effectiveness of such a routine. Over 8% of all girls will have a UTI during childhood. About 87 individuals in a million will develop end-stage renal disease (ESRD) by the age of 60 years, caused in about 9% by pyelonephritis (PN) or reflux nephropathy. From these statistics, the maximal risk of a first diagnosed UTI progressing to ESRD is approximately 1:10,000. The risk of developing hypertension following a first UTI in childhood, without eventual evolution to ESRD, appears to be very small. The cost of the widely recommended routine imaging procedures ranges from U.S. $355 in Britain to U.S. $1,090 in the United States. The minimal cost of preventing a single progression to ESRD by early diagnosis of underlying pathology-if this were possible in all cases-would range between U.S. $5 million in Britain and U.S. $15 million in the United States. Since in many instances progressive renal damage can not be prevented, the true cost is considerably higher. Lower UTI in girls is a very common and, in most cases, benign finding in primary-care practice. It is suggested that girls with afebrile UTI, presenting with lower urinary tract symptoms alone, need not undergo any imaging procedures, but should be followed with urine examinations and cultures at the time of febrile illness. The recommended investigative routines should be reserved for UTI in infants and in girls with fever or other symptoms suggesting PN, and for proven recurrent UTI. Such a regimen will allow a marked saving in terms of costs and in terms of unnecessary radiation, psychological stress to children, and stress, inconvenience, and time loss to parents. There is no evidence that this approach will compromise the course or final outcome of this very common condition.

Entities:  

Mesh:

Year:  1997        PMID: 9090657     DOI: 10.1007/s004670050252

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  Prognosis for vesicoureteric reflux.

Authors:  K V Jones
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Cardiac causes for syncope or sudden death in childhood.

Authors:  C Wren
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 3.  Urinary tract infection in children.

Authors:  J Larcombe
Journal:  BMJ       Date:  1999-10-30

Review 4.  Urinary tract infections in children: recommendations for antibiotic prophylaxis and evaluation. An evidence-based approach.

Authors:  Paul A Merguerian; Einar F Sverrisson; Daniel B Herz; Leslie T McQuiston
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

Review 5.  [Modern imaging technology for childhood urinary tract infection].

Authors:  M Riccabona; R Fotter
Journal:  Radiologe       Date:  2005-12       Impact factor: 0.635

6.  Wilms tumour minisymposium.

Authors:  Thomas L Slovis
Journal:  Pediatr Radiol       Date:  2007-11-17

Review 7.  Imaging in childhood urinary tract infections: time to reduce investigations.

Authors:  Stephen D Marks; Isky Gordon; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2007-08-01       Impact factor: 3.714

8.  Clinical course of prenatally detected primary vesicoureteral reflux.

Authors:  José Maria Penido Silva; Eduardo Araujo Oliveira; José Silvério Santos Diniz; Maria Cândida Ferrarez Bouzada; Renata Moura Vergara; Barbara Caldeira Souza
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

9.  An audit of RCP guidelines on DMSA scanning after urinary tract infection.

Authors:  P V Deshpande; K V Jones
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

Review 10.  Vesicoureteric reflux and reflux nephropathy.

Authors:  Chulananda D A Goonasekera; Chandra K Abeysekera
Journal:  Indian J Pediatr       Date:  2003-03       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.